《ClinicaChimicaActa,3月13日,Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-16
  • Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

    GiuseppeLippi, MarioPlebani, BrandonMichael Henry

    Show more

    https://doi.org/10.1016/j.cca.2020.03.022

    Abstract

    Background

    Coronavirus disease 2019 (COVID-19) is a novel infectious disease with lack of established laboratory markers available to evaluate illness severity. In this study, we investigate whether platelet count could differentiate between COVID-19 patients with or without severe disease. Additionally, we evaluate if thrombocytopenia is associated with severe COVID-19.

  • 原文来源:https://www.sciencedirect.com/science/article/pii/S0009898120301248
相关报告
  • 《ClinicaChimicaActa,3月4日,Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-08
    • Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis GiuseppeLippi, MarioPlebani Show more https://doi.org/10.1016/j.cca.2020.03.004 Coronavirus disease 2019 (COVID-19), a new form of respiratory and systemic disorder sustained by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now producing an outbreak of pandemic proportions, whereby nearly 90,000 people have already been infected around the world, 10-15% of whom with severe disease and over 2900 already died [1]. A severe form of pneumonia, potentially evolving towards adult respiratory distress syndrome (ARDS) and occasionally associated with multiorgan failure, are the leading complications of this respiratory virus [2].
  • 《MedRxiv,3月16日,Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-17
    • Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection Vageesh Jain, Jin-Min Yuan doi: https://doi.org/10.1101/2020.03.15.20035360 Abstract Background/introduction COVID−19, a novel coronavirus outbreak starting in China, is now a rapidly developing public health emergency of international concern. The clinical spectrum of COVID−19 disease is varied, and identifying factors associated with severe disease has been described as an urgent research priority. It has been noted that elderly patients with pre-existing comorbidities are more vulnerable to more severe disease. However, the specific symptoms and comorbidities that most strongly predict disease severity are unclear. We performed a systematic review and meta-analysis to identify the symptoms and comorbidities predictive of COVID−19 severity. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.